Dive Brief:
- Zimmer Biomet has partnered with RevelAi Health to market clinical software powered by generative artificial intelligence.
- RevelAi is using AI to automate clinical workflows and support patients with conditions such as osteoarthritis. The company aims to improve patient outcomes while reducing clinician burnout.
- Zimmer, which announced the partnership Wednesday, has struck a multi-year co-marketing agreement to sell RevelAi’s patient care management platform and care team dashboard for healthcare providers.
Dive Insight:
Zimmer is primarily an orthopedic company, with knee and hip devices accounting for around two-thirds of its sales in 2023. However, Zimmer CEO Ivan Tornos used the company’s investor day in May to set out a broader vision for the business that goes beyond selling implants. Tornos wants Zimmer to focus on solving the problems faced by patients, physicians, providers and payers.
RevelAi, formerly Azra Care, has an overlapping objective. The company has developed software for management of fall-related fractures, osteoarthritis and other musculoskeletal conditions to improve outcomes, minimize expenses and ensure equitable access to care. RevelAi works with health systems, ambulatory surgery centers (ASCs) and payers. Zimmer sees ASCs as a growth opportunity.
Through RevelAi Care Coach, the company provides instant patient messaging and inbox management to reduce the burden on care teams. The platform uses conversational AI to provide personalized support to patients. RevelAi has also developed a care team dashboard for AI-powered triage.
The technologies are designed to help providers transition from fee-for-service to value-based care. RevelAi is aiming to improve patient adherence to treatment, reduce readmissions, and support Centers for Medicare and Medicaid Services compliance.
Zimmer framed its interest in the software as part of its recognition that medical care is only one driver of health outcomes. Socioeconomic, environmental and behavioral factors matter too. By working with RevelAi, Zimmer wants to “create an equity-driven, whole-person approach to value-based care using integrated AI-enabled tools to enhance orthopedic care.”
Correction: This story was corrected to state the technology is generative artificial intelligence.
